| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.41 | 0.006 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |